Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib. [PDF]
Liang EC +10 more
europepmc +1 more source
Real-world characteristics of systemic mastocytosis in Romania: insights from a reference-center-based descriptive study. [PDF]
Soare D +8 more
europepmc +1 more source
Defining "Normal" basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis. [PDF]
Crupi F, Caroprese J, Mannelli F.
europepmc +1 more source
Patient and Advanced Practitioner Perspectives on Symptom Burden and Symptom Management in Indolent Systemic Mastocytosis. [PDF]
Kurtin S +4 more
europepmc +1 more source
Digital polymerase chain reaction enhances analysis of the cKIT D816V mutation in systemic mastocytosis patients: Clinical insights. [PDF]
Kayano AE +7 more
europepmc +1 more source
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System. [PDF]
Aperna F +13 more
europepmc +1 more source
Avapritinib in the treatment of systemic mastocytosis with associated acute myeloid leukemia after poor graft function following allogeneic hematopoietic stem cell transplantation: a case study and review of the literature. [PDF]
Mi R +6 more
europepmc +1 more source
Triptasa: funció biològica i valor semiològic de la seva concentració en diferents líquids biològics [PDF]
Morandeira Rego, F.
core
Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why. [PDF]
Cilloni D +5 more
europepmc +1 more source

